Loading...
Intuitive Surgical, Inc.
ISRG•NASDAQ
HealthcareMedical - Instruments & Supplies
$557.08
$-0.98(-0.18%)
Intuitive Surgical, Inc. (ISRG) Financial Performance & Statements
Review Intuitive Surgical, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
17.24%
↑ 17.24%
Operating Income Growth
32.95%
↑ 32.95%
Net Income Growth
29.18%
↑ 29.18%
Operating Cash Flow Growth
33.15%
↑ 33.15%
Operating Margin
28.20%
↑ 28.20%
Gross Margin
67.09%
↑ 67.09%
Net Profit Margin
28.41%
↑ 28.41%
ROE
15.52%
↑ 15.52%
ROIC
13.90%
↑ 13.90%
Intuitive Surgical, Inc. (ISRG) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Intuitive Surgical, Inc. stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $2.41B | $2.04B | $2.010B | $1.89B |
Cost of Revenue | $771.30M | $664.20M | $637.20M | $645.20M |
Gross Profit | $1.64B | $1.37B | $1.37B | $1.25B |
Gross Profit Ratio | $0.68 | $0.67 | $0.68 | $0.66 |
R&D Expenses | $294.70M | $286.00M | $280.10M | $284.50M |
SG&A Expenses | $612.60M | $510.60M | $525.30M | $491.50M |
Operating Expenses | $907.30M | $796.60M | $805.40M | $776.00M |
Total Costs & Expenses | -$1.68B | $1.46B | $1.44B | $1.42B |
Interest Income | $74.90M | $0.00 | $87.20M | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $74.90M | $116.20M | $111.80M | $109.30M |
EBITDA | $809.80M | $693.50M | $679.10M | $578.70M |
EBITDA Ratio | $0.34 | $0.34 | $0.34 | $0.31 |
Operating Income | $734.90M | $577.30M | $567.30M | $469.40M |
Operating Income Ratio | $0.30 | $0.28 | $0.28 | $0.25 |
Other Income/Expenses (Net) | $74.90M | $93.70M | $87.20M | $69.10M |
Income Before Tax | $809.80M | $671.00M | $654.50M | $538.50M |
Income Before Tax Ratio | $0.34 | $0.33 | $0.33 | $0.28 |
Income Tax Expense | $121.80M | $100.40M | $123.00M | -$8.90M |
Net Income | $685.70M | $565.10M | $526.90M | $544.90M |
Net Income Ratio | $0.28 | $0.28 | $0.26 | $0.29 |
EPS | $1.92 | $1.59 | $1.48 | $1.54 |
Diluted EPS | $1.88 | $1.56 | $1.46 | $1.51 |
Weighted Avg Shares Outstanding | $356.40M | $355.80M | $355.00M | $353.50M |
Weighted Avg Shares Outstanding (Diluted) | $363.90M | $362.70M | $361.00M | $360.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan